RESUMEN
INTRODUCTION: Hypothalamic invasion in pediatric patients with craniopharyngioma negatively influences clinical outcomes. It has been shown that radiologic classification of hypothalamic invasion can effectively predict surgical strategies to minimize postoperative comorbidities in pediatric patients. However, no comparative analysis has been performed in adult patients with craniopharyngioma. This study implements the previously established radiologic classification to characterize postoperative morbidity, surgical outcome, and distress in adult patients with craniopharyngioma. METHODS: Electronic medical records of 22 adult patients with craniopharyngioma were used to analyze patient demographics, surgical data, endocrinologic and ophthalmologic status, and histopathology in a retrospective single-center study. Questionnaires regarding postoperative distress (National Comprehensive Cancer Network Distress Thermometer and Problem List), comorbidities (Charlson Comorbidity Index), employment status, and need for supportive care were distributed. Magnetic resonance imaging scans were categorized according to Puget et al. RESULTS: Patients with hypothalamic involvement show significantly higher rates of postoperative diabetes insipidus and higher scores on the National Comprehensive Cancer Network Distress Thermometer. This significant difference was lost when considering postoperative Puget grades. Puget grades 1 and 2 were found to be associated with the use of a subfrontal surgical approach (hazard ratio, 4.080; confidence interval, 1.153-14.431; P = 0.029). CONCLUSIONS: Our results point toward a possible predictive role of preoperative hypothalamic invasion for postoperative diabetes insipidus as well as higher perceived levels of distress after surgery, which may be established in larger patient cohorts. Furthermore, a subfrontal surgical approach seems to be predicted by tumors with hypothalamic invasion. In this case, preoperative magnetic resonance imaging grading may help guide the planning of an optimal surgical strategy for adults with craniopharyngioma to reduce postoperative morbidity.
Asunto(s)
Craneofaringioma , Diabetes Insípida , Neoplasias Hipotalámicas , Neoplasias Hipofisarias , Adulto , Humanos , Niño , Craneofaringioma/diagnóstico por imagen , Craneofaringioma/cirugía , Craneofaringioma/patología , Estudios Retrospectivos , Neoplasias Hipofisarias/diagnóstico por imagen , Neoplasias Hipofisarias/cirugía , Neoplasias Hipofisarias/patología , Hipotálamo/diagnóstico por imagen , Hipotálamo/cirugía , Hipotálamo/patología , Neoplasias Hipotalámicas/patología , Resultado del TratamientoRESUMEN
BACKGROUND: Lesions located in the pineal region represent a surgical challenge. Multiple approaches to this region have been described, each with its advantages and disadvantages. We report the first application of the endoscopic supracerebellar infratentorial approach for complete resection of a pineal tumor. Unlike transventricular endoscopy, this technique poses no risk to the fornices and can be applied independent of ventricular size. CASE DESCRIPTION: A 21-year-old man sought treatment for diplopia. Magnetic resonance images of brain revealed a heterogeneous, contrast-enhancing mass that originated from the pineal gland. This tumor exerted the mass effect on the tectum and invaded to the bilateral dorso-medial thalamus and hypothalamus but caused no obstructive hydrocephalus. The results of a cytological study of the cerebrospinal fluid, alpha-fetoprotein, and beta-human chorionic gonadotropin were negative. The patient was referred for the surgical work-up. TECHNIQUE: The patient was positioned in the semi-sitting position. The supracerebellar infratentoria corridor was accessed through two paramedian burr holes, which provided natural by-gravity cerebellar traction. The excellent illumination and magnification without sacrificing the inferior occipital sinus could be achieved with the aid of the endoscope. The pineal tumor was resected completely via the full-endoscopic approach. Postoperatively, the patient's diplopia resolved completely, and his hospital course was uneventful. CONCLUSIONS: Taking the advantages of the endoscope and peculiar supracerebellar infratentoria corridor, we could successfully remove the gross-total tumor without violating the critical neurovascular structures. Moreover, this approach can be performed regardless of the size of the ventricle. Consequently, it is an excellent minimally invasive surgical option for resection of symptomatic pineal tumor.
Asunto(s)
Endoscopía/métodos , Neoplasias de Células Germinales y Embrionarias/cirugía , Procedimientos Neuroquirúrgicos/métodos , Pinealoma/cirugía , Craneotomía/métodos , Diplopía/etiología , Humanos , Neoplasias Hipotalámicas/patología , Imagen por Resonancia Magnética , Masculino , Neoplasias de Células Germinales y Embrionarias/patología , Pinealoma/patología , Cráneo/anatomía & histología , Cráneo/cirugía , Tálamo/patología , Resultado del Tratamiento , Adulto JovenRESUMEN
Patients with craniopharyngioma (CP), a tumor located in the pituitary and/or hypothalamus, are susceptible to developing obesity and many metabolic complications. The study aim was to create a rodent model that mimics the complex neuroanatomical and metabolic disturbances commonly seen in obese CP patients. We compared the metabolic phenotype of animals with three distinct types of hypothalamic lesions: 1) destruction of the arcuate nucleus (ARC) induced by monosodium glutamate (MSG), 2) electrolytic lesion of the adjacent ventromedial nucleus (VMN) alone, 3) both the VMN and dorsomedial nucleus (DMN), or a 4) combined medial hypothalamic lesion (CMHL) affecting the VMN, DMN, and the ARC. Only the CMHL model exhibited all key features observed in patients with hypothalamic obesity induced by CP. These features included excessive weight gain due to increased adiposity, increased food intake, and pronounced hyperinsulinemia and hyperleptinemia. Similar to characteristics of patients with CP, CMHL animals exhibited reduced plasma levels of alpha-melanocyte stimulating hormone and reduced ambulatory activity compared with weight-matched controls. Therefore, the CMHL model best mimics the complex metabolic abnormalities observed in obese CP patients compared with lesions to other hypothalamic areas and provides a foundation for future pharmacological approaches to treat obesity in children with hypothalamic damage.
Asunto(s)
Craneofaringioma/complicaciones , Modelos Animales de Enfermedad , Neoplasias Hipotalámicas/complicaciones , Obesidad/etiología , Neoplasias Hipofisarias/complicaciones , Animales , Núcleo Arqueado del Hipotálamo/efectos de los fármacos , Núcleo Arqueado del Hipotálamo/patología , Peso Corporal , Niño , Craneofaringioma/patología , Núcleo Hipotalámico Dorsomedial/metabolismo , Núcleo Hipotalámico Dorsomedial/patología , Ingestión de Alimentos , Metabolismo Energético , Femenino , Homeostasis , Humanos , Neoplasias Hipotalámicas/patología , Hipotálamo/anatomía & histología , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Hipotálamo/patología , Masculino , Neoplasias Hipofisarias/patología , Embarazo , Ratas , Ratas Sprague-Dawley , Glutamato de Sodio/efectos adversos , Núcleo Hipotalámico Ventromedial/metabolismo , Núcleo Hipotalámico Ventromedial/patologíaRESUMEN
PURPOSE: The purpose of this study was to investigate the potential value of neuroendoscopic biopsies in pediatric patients with peri- or intraventricular tumors. METHODS: From 2001 to 2008, 49 pediatric patients (mean age, 12.16 years) with tumors located in the intraventricular or paraventricular areas underwent neuroendoscopic biopsy, with or without simultaneous endoscopic third ventriculostomy. Neuroendoscopic biopsies were performed to verify the histological diagnosis of neoplasms and to establish pathological diagnoses necessary for planning appropriate treatment strategies. RESULTS: In 45 of 49 patients (91.8%) neuroendoscopic biopsy specimens were appropriate for diagnosis and revealed 27 germinomas, 11 astrocytomas, and one ependymoma, etc. The tumor location included the pineal gland (n = 28), thalamus (n = 7), intraventricle (n = 3), hypothalamus (n = 3), suprasellar area (n = 2), and diffuse multifocal area (n = 3). In two patients (4.1%) biopsy specimens were informative but not diagnostic. Tumor tissue specimens were undiagnostic in two patients (4.1%). There were eight transient morbidities, including four EOM limitations, two central DI, one EVD infection, and one CSF leakage. One patient experienced postoperative tumor bleeding requiring emergent operation. There was no case of operative mortality. CONCLUSION: Neuroendoscopic biopsy can be considered as the first choice for tissue sampling of periventricular and intraventricular tumors with acceptable risks.
Asunto(s)
Biopsia/métodos , Neoplasias Encefálicas/patología , Neoplasias del Ventrículo Cerebral/patología , Neoplasias Hipotalámicas/patología , Neuroendoscopía/métodos , Pinealoma/patología , Enfermedades Talámicas/patología , Adolescente , Ventrículos Cerebrales/patología , Niño , Preescolar , Estudios de Factibilidad , Femenino , Humanos , Hipotálamo/patología , Lactante , Masculino , Glándula Pineal/patología , Complicaciones Posoperatorias/etiología , Tálamo/patología , Adulto JovenRESUMEN
OBJECTIVE: We aim to report a case of Kaposi sarcoma (KS) with Cushing's syndrome caused by endogenic glucocorticoid-induced immunosuppression. CLINICAL PRESENTATION: A 43-year-old woman presented with delirium, hirsutism, fatigue, and hypertension. At the time of presentation, physical findings showed a Cushingoid appearance, with moon-like facies, hirsutism, and hyperpigmentation. Laboratory findings showed the following: adrenocorticotropic hormone, 86.7 pg/mL (normal range, 0-46 pg/mL); baseline cortisol level, 50 microg/dL (normal range, 6.2-19 microg/dL); potassium, 2.2 mEq/L (normal range, 3.5-5 mEq/L); and midnight cortisol level, 33 microg/dL. Serum cortisol levels failed to suppress after low and high doses of dexamethasone; these findings confirmed the diagnosis of ectopic adrenocorticotropic hormone production. Magnetic resonance imaging revealed a 12 x 15-mm, round, hypothalamic mass lesion in the center of the median eminence. INTERVENTION: Endoscopic biopsy from the floor of the third ventricle was performed, and pathological examination of the lesion showed a diffuse adrenocorticotropic hormone-secreting adenoma. The patient developed diffuse skin lesions that were proven to be a KS by skin biopsy while she was prepared for transcranial surgery. After surgical removal of the adenoma, she became hypocortisolemic and required cortisol replacement. Within 1 month after surgery, all KS lesions disappeared spontaneously. CONCLUSION: Excessive cortisol may induce immunosuppression. KS is one of the most common malignant tumors of patients with immunosuppression. To the best of our knowledge, this is the first case of Cushing's syndrome with KS caused by endogenous glucocorticoid-induced immunosuppression.
Asunto(s)
Síndrome de ACTH Ectópico/inmunología , Adenoma/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Neoplasias Hipotalámicas/metabolismo , Neoplasias Hipofisarias/metabolismo , Sarcoma de Kaposi/inmunología , Síndrome de ACTH Ectópico/patología , Síndrome de ACTH Ectópico/fisiopatología , Adenoma/patología , Adenoma/cirugía , Hormona Adrenocorticotrópica/sangre , Adulto , Coristoma/patología , Coristoma/fisiopatología , Coristoma/cirugía , Síndrome de Cushing/complicaciones , Síndrome de Cushing/inmunología , Síndrome de Cushing/fisiopatología , Femenino , Humanos , Hidrocortisona/sangre , Neoplasias Hipotalámicas/patología , Neoplasias Hipotalámicas/cirugía , Hipotálamo/metabolismo , Hipotálamo/patología , Hipotálamo/cirugía , Tolerancia Inmunológica/inmunología , Huésped Inmunocomprometido/inmunología , Imagen por Resonancia Magnética , Eminencia Media/metabolismo , Eminencia Media/patología , Eminencia Media/cirugía , Procedimientos Neuroquirúrgicos , Neoplasias Hipofisarias/patología , Neoplasias Hipofisarias/cirugía , Sarcoma de Kaposi/patología , Sarcoma de Kaposi/fisiopatología , Resultado del TratamientoRESUMEN
INTRODUCTION: In this study, we have investigated the role of leptin, soluble leptin receptor(sOb-R), resistin, and insulin secretory dynamics in the development of hypothalamic obesity. MATERIALS AND METHODS: Children who had hypothalamo-pituitary tumor were divided into two groups. First group included obese-overweight (hypothalamic obese = HOB group, n = 23) and second group included non-obese children (hypothalamic non-obese = HNOB group, n = 16). Exogenously obese-overweight children (OB group, n = 22) were included as controls. Basal and second-hour serum glucose and insulin in oral glucose tolerance test (OGTT), basal serum leptin, sOb-R, resistin levels, and homeostasis model assessment (HOMA) indexes were compared between the groups. RESULTS: Age, sex, and pubertal status were similar in study groups. Median and interquartile ranges of body mass index (BMI) z scores were similar in HOB and OB groups (2.0 (1.5-2.1) and 2.1 (1.8-2.3), respectively). Serum leptin levels corrected for BMI were highest and total leptin/sOb-R ratios (free leptin index (FLI)) tended to be higher in HOB than HNOB and OB groups, indicating leptin resistance (leptin/BMI, 4.0 (1.6-5.2), 1.5 (0.8-3.1), and 2.5 (1.8-3.5); FLI, 2.0 (0.8-3.5), 0.6 (0.3-1.2), and 1.5 (1-2.3) in HOB, HNOB, and OB groups; respectively). Serum resistin levels were similar in groups (2.6 (1.9-3.1), 2.8 (1.7-3.4), and 3.0 (2.2-3.5) ng/ml in HOB, HNOB, and OB groups, respectively). Basal serum glucose, basal and second-hour insulin levels in OGTT, and HOMA index were higher in OB group than the HOB and HNOB groups, indicating insulin resistance in simple obesity; however, increment of insulin to same glycemic load in OGTT was highest in the HOB group indicating insulin dysregulation (p < 0.05). CONCLUSION: Hypothalamic obesity seems to be related to both dysregulated afferent (leptin) and efferent (insulin) neural outputs through the autonomic nervous system resulting in energy storage as fat.
Asunto(s)
Hipotálamo/metabolismo , Hipotálamo/fisiopatología , Insulina/fisiología , Leptina/fisiología , Obesidad/metabolismo , Obesidad/fisiopatología , Receptores de Leptina/fisiología , Resistina/fisiología , Adolescente , Astrocitoma/metabolismo , Astrocitoma/patología , Astrocitoma/fisiopatología , Índice de Masa Corporal , Niño , Craneofaringioma/metabolismo , Craneofaringioma/patología , Craneofaringioma/fisiopatología , Disgerminoma/metabolismo , Disgerminoma/patología , Disgerminoma/fisiopatología , Femenino , Prueba de Tolerancia a la Glucosa , Índice Glucémico , Homeostasis/fisiología , Humanos , Neoplasias Hipotalámicas/metabolismo , Neoplasias Hipotalámicas/patología , Neoplasias Hipotalámicas/fisiopatología , Hipotálamo/patología , Insulina/sangre , Leptina/sangre , Masculino , Resistina/sangreRESUMEN
We here report an unusual tumor of the suprasellar region featuring a papillary growth pattern and cytokeratin expression in a 10-year-old boy with tuberous sclerosis. This hitherto undescribed low-grade hypothalamic tumor extends the spectrum of tumors associated with the tuberous sclerosis complex.
Asunto(s)
Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Esclerosis Tuberosa/complicaciones , Biomarcadores de Tumor/análisis , Niño , Análisis Mutacional de ADN , Regulación Neoplásica de la Expresión Génica , Humanos , Neoplasias Hipotalámicas/química , Neoplasias Hipotalámicas/etiología , Neoplasias Hipotalámicas/genética , Neoplasias Hipotalámicas/terapia , Hipotálamo/química , Imagen por Resonancia Magnética , Masculino , Resultado del Tratamiento , Esclerosis Tuberosa/patologíaRESUMEN
A 59-year-old woman presented with disturbance of consciousness and decreased visual acuity caused by a suprasellar mass identified on MRI. A bifrontal interhemispheric approach allowed removal of the top and lateral sides of the tumor from the wall of the third ventricle. The hypothalamus appeared to be the origin of the mass, which proved to be hemangioblastoma, a rare tumor in this location.
Asunto(s)
Neoplasias del Ventrículo Cerebral/patología , Hemangioblastoma/patología , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Tercer Ventrículo/patología , Antígenos CD34/análisis , Antígenos CD34/metabolismo , Biomarcadores de Tumor , Capilares/patología , Neoplasias del Ventrículo Cerebral/irrigación sanguínea , Neoplasias del Ventrículo Cerebral/cirugía , Trastornos de la Conciencia/etiología , Femenino , Hemangioblastoma/irrigación sanguínea , Hemangioblastoma/cirugía , Humanos , Neoplasias Hipotalámicas/irrigación sanguínea , Neoplasias Hipotalámicas/cirugía , Imagen por Resonancia Magnética , Persona de Mediana Edad , Procedimientos Neuroquirúrgicos , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/análisis , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/metabolismo , Silla Turca/anatomía & histología , Células del Estroma/patología , Tercer Ventrículo/cirugía , Resultado del Tratamiento , Baja Visión/etiologíaRESUMEN
BACKGROUND AND PURPOSE: Pilocytic astrocytoma (PA) is a WHO grade I tumor of the central nervous system mostly arising in children and young adults. Management of diencephalic PA is a difficult challenge. Surgical treatment has to cope with both the difficulties of deep location and eloquent area tumors. MATERIALS AND METHODS: We retrospectively reviewed seven pediatric cases (female: 4, male: 3) of diencephalic PA. Opto-chiasmatic tumors were excluded from the series. Mean age at diagnosis was 108 months (9 years) (range: 4 month-18 years), median age was 111 months. Median follow-up for the series was 125 months. Tumor locations were as followed: right thalamus: 2, both thalami: 1, hypothalamus: 3, and right basal ganglia: 1. At the onset, the first symptom was mostly raised intracranial pressure. The delay in diagnosis ranged from 48 hours up to 6 years. TREATMENT: a shunting procedure was performed in 3 patients, a direct surgical approach in 5 patients (gross total removal: 2; partial removal: 3) and one patient had only a biopsy. Three children were re-operated. Three patients were treated by radiationtherapy (RT) after surgery. Chemotherapy was delivered for 4 children. RESULTS: The overall survival rate was 71.4 months (almost 6 years) (range: 3-184 months). Median survival rate was 42 months (3.5 years). Three children died, two by tumor progression and one death related to late side-effects of RT. Four patients have a good quality of life with GOS I (n = 3) or II (n = 1). We observed tumor regression in two patients at 1 and 17 years after the beginning of treatment. Correct diagnosis was only made for two cases at the initial pathological examination. CONCLUSION: The course of diencephalic PA is still unpredictable. The tumor can be controlled by a partial surgical removal, and a residual tumor can sometimes decrease in size after surgery. Gross total removal of these tumors, although difficult, may be performed. With cranial navigation systems, the risk is low. Pathological diagnosis is sometimes difficult to assess.
Asunto(s)
Astrocitoma/cirugía , Neoplasias Encefálicas/cirugía , Neoplasias Hipotalámicas/cirugía , Enfermedades Talámicas/cirugía , Adolescente , Astrocitoma/diagnóstico , Astrocitoma/mortalidad , Astrocitoma/patología , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/mortalidad , Neoplasias Encefálicas/patología , Quimioterapia Adyuvante , Niño , Preescolar , Terapia Combinada , Dominancia Cerebral/fisiología , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Hipotalámicas/diagnóstico , Neoplasias Hipotalámicas/mortalidad , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Hipotálamo/cirugía , Lactante , Imagen por Resonancia Magnética , Masculino , Calidad de Vida , Radioterapia Adyuvante , Reoperación , Estudios Retrospectivos , Tasa de Supervivencia , Enfermedades Talámicas/diagnóstico , Enfermedades Talámicas/mortalidad , Enfermedades Talámicas/patología , Tálamo/patología , Tálamo/cirugía , Tomografía Computarizada por Rayos XAsunto(s)
Hipopituitarismo/etiología , Neoplasias Hipotalámicas/complicaciones , Aumento de la Imagen , Linfoma de Células B/complicaciones , Imagen por Resonancia Magnética , Adulto , Diagnóstico Diferencial , Humanos , Hipopituitarismo/patología , Hipopituitarismo/cirugía , Neoplasias Hipotalámicas/patología , Neoplasias Hipotalámicas/cirugía , Hipotálamo/patología , Hipotálamo/cirugía , Linfoma de Células B/patología , Linfoma de Células B/cirugía , Masculino , Sensibilidad y EspecificidadRESUMEN
PURPOSE: Obesity is a common consequence in patients with tumors of the hypothalamic region and of related treatment in children. Much less information is available on adult patients and long-term survivors. The aims of this study were to estimate the prevalence of obesity in adult patients with acquired structural hypothalamic damage and to define the characteristics of patients at greatest risk of obesity. METHODS: A retrospective study was conducted of 52 patients (25 women; median age at diagnosis, 44 years; range, 17 to 78 years) with tumors involving the hypothalamic region. These included 22 craniopharyngiomas, 24 pituitary adenomas, and six other hypothalamic tumors. Changes in body mass index were determined, magnetic resonance imaging scans were scored by a radiologist for tumor size and the extent of involvement of the hypothalamus, and current hormone replacement therapy was recorded, to identify possible features associated with new or worsened obesity (defined as a body mass index > or =30 kg/m(2) at the latest follow-up, which had increased by at least 2 kg/m(2) since diagnosis of the tumor). RESULTS: Serial body mass index data from diagnosis to the latest follow-up were available for 42 patients. After a median of 5 years (range, 1 to 19 years) of follow-up, most patients with hypothalamic damage were obese (52% [n = 22] vs. 24% [n = 10] at the time of diagnosis, P < 0.0001). In a multivariate model, use of desmopressin (odds ratio [OR] = 13; 95% confidence interval [CI]: 2.0 to 86; P = 0.007) and growth hormone replacement (OR = 7.6; 95% CI: 1.1 to 51; P = 0.04) were associated with new or worsened obesity during follow-up. No correlation was found between the initial size or location of the tumor and subsequent weight gain. CONCLUSION: Obesity is highly prevalent in adult survivors of hypothalamic tumors. Use of desmopressin and growth hormone therapy, but not size or location of the tumor, were associated with weight gain and obesity following diagnosis. These findings may be helpful in identifying patients at increased risk of obesity, to whom earlier intervention could be offered.
Asunto(s)
Neoplasias Hipotalámicas/complicaciones , Hipotálamo/patología , Obesidad/etiología , Aumento de Peso , Adolescente , Adulto , Anciano , Índice de Masa Corporal , Intervalos de Confianza , Desamino Arginina Vasopresina/administración & dosificación , Desamino Arginina Vasopresina/efectos adversos , Femenino , Hormona del Crecimiento/administración & dosificación , Hormona del Crecimiento/efectos adversos , Humanos , Neoplasias Hipotalámicas/tratamiento farmacológico , Neoplasias Hipotalámicas/patología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Obesidad/inducido químicamente , Obesidad/patología , Oportunidad Relativa , Prevalencia , Fármacos Renales/administración & dosificación , Fármacos Renales/efectos adversos , Estudios RetrospectivosRESUMEN
We report an unusual case of primary hypothalamic lymphoma with hypopituitarism presenting as Stiff-man syndrome (SMS). A 64-year-old man was hospitalized due to a 3-week history of general weakness, anorexia, vomiting, weight loss, and muscle pain and spasms precipitated by motion and tactile stimuli resulting in muscle stiffness and difficulty in mobility. Physical examination revealed normal sensorimotor function and reflexes, except for bitemporal visual field defect. Routine laboratory and gastrointestinal examinations provided no remarkable clues. Endocrine assessment revealed low levels of morning cortisol, thyroxine, and anterior pituitary hormones but an increase in prolactin level. The patient's muscle pain and stiffness improved dramatically within 2 days after hydrocortisone therapy and thyroxine replacement. Magnetic resonance imaging (MRI) of the brain confirmed an 18-mm enhancing hypothalamic tumor with optic chiasm involvement, which proved to be a B-cell lymphoma. The results of the extensive studies for systemic lymphoma were negative, suggesting a primary hypothalamic lymphoma. The tumor regressed completely and was invisible on MRI scan after adjuvant radiotherapy. The patient's condition was satisfactory and there was no recurrence of SMS during the 2-year follow-up period. This case demonstrated that primary hypothalamic lymphoma complicated with adrenal insufficiency may manifest as SMS. Early diagnosis and prompt intervention can lead to a favorable outcome and reduce morbidity.
Asunto(s)
Hipopituitarismo/diagnóstico , Neoplasias Hipotalámicas/diagnóstico , Linfoma de Células B/diagnóstico , Síndrome de la Persona Rígida/diagnóstico , Insuficiencia Suprarrenal/diagnóstico , Encéfalo/patología , Diagnóstico Diferencial , Humanos , Hipopituitarismo/patología , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Linfoma de Células B/patología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Factores de TiempoRESUMEN
The authors report the case of a hypothalamic ganglioglioma with left-sided temporal lobe extension in an 8-year-old girl who presented with seizures. Other cases of ganglioglioma involving the hypothalamus have been reported in the literature; however, this site of origin is exceedingly rare and worthy of report. Treatment involved medial temporal lobectomy with the hypothalamic component of the tumor remaining untouched. The patient recovered postoperatively with no neurological deficits and was seizure free at 12 months. Neither radio- nor chemotherapy was recommended because of the tumor histology, location, and the patient's age. The authors recommend follow up and surgical treatment for possible tumor recurrence. The prognosis for hypothalamic ganglioglioma is unknown.
Asunto(s)
Lobectomía Temporal Anterior , Epilepsia Parcial Compleja/cirugía , Ganglioglioma/cirugía , Neoplasias Hipotalámicas/cirugía , Niño , Dominancia Cerebral/fisiología , Epilepsia Parcial Compleja/diagnóstico , Epilepsia Parcial Compleja/patología , Femenino , Ganglioglioma/diagnóstico , Ganglioglioma/patología , Humanos , Neoplasias Hipotalámicas/diagnóstico , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Hipotálamo/cirugía , Pronóstico , Lóbulo Temporal/patología , Lóbulo Temporal/cirugíaRESUMEN
BACKGROUND: Cavernomas are rarely located in the third ventricle, hypothalamus, or thalamus. In this report, we present our experience managing a patient with three cavernomas, one each in the floor of the third ventricle, hypothalamus, and left thalamus. CASE PRESENTATION: This 62-year-old woman had had an unsteady gait and weakness of both legs for six months. Magnetic resonance imaging (MRI) revealed multiple intracranial tumours in the third ventricle, hypothalamus, and left thalamus. The third ventricle tumour was found to be a cavernoma by intra-operative endoscopic examination and then was excised via a transcortical, transventricular approach. Pathology revealed a cavernoma. The other two tumours were assumed to be cavernomas because of their MRI features. Three days after surgery, the patient developed right hemiparesis and disturbance of consciousness. Computed tomography revealed a left thalamic haemorrhage. After conservative treatment, her conscious level gradually recovered and she could walk with support seven months after surgery. INTERPRETATION: Our experience with this rare case of multiple, deep-seated cavernomas suggests that management of such patients requires specific consideration of the clinical manifestations, location, size, and previous bleeding history.
Asunto(s)
Neoplasias Encefálicas/patología , Hemangioma Cavernoso del Sistema Nervioso Central/patología , Neoplasias Hipotalámicas/patología , Neoplasias Primarias Secundarias/patología , Tálamo/patología , Tercer Ventrículo/patología , Neoplasias Encefálicas/cirugía , Hemorragia Cerebral , Femenino , Hemangioma Cavernoso del Sistema Nervioso Central/cirugía , Humanos , Neoplasias Hipotalámicas/cirugía , Imagen por Resonancia Magnética , Persona de Mediana Edad , Neoplasias Primarias Secundarias/cirugía , Tálamo/cirugía , Tercer Ventrículo/cirugía , Tomografía Computarizada por Rayos XAsunto(s)
Carcinoma de Pulmón de Células no Pequeñas/secundario , Neoplasias Hipotalámicas/patología , Neoplasias Hipotalámicas/secundario , Hipotálamo/patología , Neoplasias Pulmonares/patología , Hipófisis/patología , Anciano , Anciano de 80 o más Años , Bradicardia/etiología , Carcinoma de Pulmón de Células no Pequeñas/complicaciones , Carcinoma de Pulmón de Células no Pequeñas/terapia , Confusión/etiología , Diabetes Insípida/diagnóstico , Diagnóstico Diferencial , Resultado Fatal , Humanos , Neoplasias Hipotalámicas/diagnóstico por imagen , Hipotálamo/diagnóstico por imagen , Hipotermia/etiología , Hipotiroidismo/diagnóstico , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/terapia , Imagen por Resonancia Magnética , Masculino , Hipófisis/diagnóstico por imagen , Hormonas Tiroideas/sangre , Tomografía Computarizada por Rayos XRESUMEN
The authors report 3 patients, 2 children and 1 adult, each of whom presented with an unusual myxoid lesion reminiscent of pilocytic astrocytoma but with other features of myxopapillary ependymoma. The magnetic resonance imaging findings in all cases showed a diffusely contrast-enhancing suprasellar mass focally extending into the third ventricle. Involvement of adjacent structures was more extensive in both infants. By light microscopy, all were composed of a monotonous population of cells with delicate piloid-like processes, loosely arranged within a prominent myxoid background. Focally, the neoplastic cells converged upon small blood vessels in pseudorosette-like formations. These histomorphologic features are identical to those of the recently described astrocytoma with monomorphous pilomyxoid features. In addition, the individual tumor cells showed strong cytoplasmic immunoreactivity with antibodies to glial fibrillary acidic protein (GFAP) and vimentin, as well as nuclear and cytoplasmic staining with S-100. All stained positive for synaptophysin and negative for chromogranin. By electron microscopy, the tumor cells were bipolar with elongated processes and apical surfaces displaying microvilli, cytoplasmic blebs and rare cilia. Vesicles and coated pits were seen, as were occasional synaptoid complexes. The current study serves to expand our clincopathologic experience with this rare and enigmatic lesion, with particular attention given to the ultrastructural characteristics.
Asunto(s)
Astrocitoma/patología , Ependimoma/patología , Neoplasias Hipotalámicas/patología , Neoplasias Hipofisarias/patología , Adulto , Ventrículos Cerebrales/patología , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Hipotálamo/patología , Masculino , Microscopía Electrónica , Invasividad Neoplásica , Hipófisis/patología , Tálamo/patologíaRESUMEN
An 8-year-old boy with neurofibromatosis type 1 (NF1) and a biopsy-proven juvenile pilocytic astrocytoma of the hypothalamic/chiasmatic region was followed with serial MRIs over 4 years. Spontaneous tumor regression was followed by progression and biopsy; 6 months later, the tumor regressed again. This bimodal regression is rare, but highlights the variable natural history of low-grade gliomas in children with NF1 and the difficulty in evaluating response of such tumors to therapy.
Asunto(s)
Astrocitoma/diagnóstico , Neoplasias Hipotalámicas/diagnóstico , Regresión Neoplásica Espontánea , Neurofibromatosis 1/diagnóstico , Quiasma Óptico , Glioma del Nervio Óptico/diagnóstico , Astrocitoma/patología , Biopsia , Ventrículos Cerebrales/patología , Niño , Progresión de la Enfermedad , Estudios de Seguimiento , Humanos , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Imagen por Resonancia Magnética , Masculino , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/patología , Neurofibromatosis 1/patología , Quiasma Óptico/patología , Glioma del Nervio Óptico/patologíaAsunto(s)
Corteza Auditiva/fisiología , Corteza Auditiva/fisiopatología , Neoplasias Hipotalámicas/fisiopatología , Hipotálamo/fisiología , Hipotálamo/fisiopatología , Adulto , Anciano , Animales , Corteza Auditiva/patología , Chinchilla , Estimulación Eléctrica , Electrodos , Electrochoque , Humanos , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Técnicas In Vitro , Masculino , Persona de Mediana Edad , Neuronas/fisiología , Neuronas/ultraestructura , Neoplasias Hipofisarias/fisiopatología , Conejos , Técnicas EstereotáxicasAsunto(s)
Neoplasias Hipotalámicas/cirugía , Neoplasias de Células Germinales y Embrionarias/cirugía , Adolescente , Biopsia , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias Hipotalámicas/diagnóstico , Neoplasias Hipotalámicas/patología , Hipotálamo/patología , Hipotálamo/cirugía , Neoplasias de Células Germinales y Embrionarias/diagnóstico , Neoplasias de Células Germinales y Embrionarias/patologíaRESUMEN
The molecular mechanisms specifying gene expression in individual neurons of the mammalian central nervous system have been difficult to study due to the cellular complexity of the brain and the absence of cultured model systems representing differentiated central nervous system neurons. We have developed clonal, differentiated, neuronal tumor cell lines of the hypothalamic GnRH-producing neurons by targeting tumorigenesis in transgenic mice. These cells (GT1 cells) provide a model system for molecular studies of GnRH gene regulation. Here we present the identification and characterization of a neuron-specific enhancer responsible for directing expression of the rat GnRH gene in GT1 hypothalamic neurons. This approximately 300 base pair (bp) upstream region (-1571 to -1863) confers enhancer activity to a short -173-bp GnRH promoter or to a heterologous promoter only in GT1 cells. The enhancer is bound by multiple GT1 nuclear proteins over its entire length. Deletion of more than 30 bp from either end dramatically reduces activity, and even large internal fragments carrying seven of the eight DNAse I-protected elements show decreased activity. Scanning replacement mutations demonstrate that several of the internal elements are required for activity of the enhancer. Thus, the GnRH gene is targeted to hypothalamic neurons by a complex multicomponent enhancer that relies on the interaction of multiple nuclear-protein binding enhancer elements.